Work

P-195: Lenalidomide, bortezomib, and dexamethasone (RVd) as first-line (1L) therapy in patients who are non-transplanted: results from the Connect® MM registry

Year: 2022

Type: conference-abstract

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00525-0

Authors: Rafat Abonour, Hans Lee, Robert Rifkin, Sikander Ailawadhi, James Omel, James Hardin, Brian Durie, Mohit Narang, Kathleen Toomey, Cristina Gasparetto, Lynne Wagner, Howard Terebelo, Jorge Mouro, Sujith Dhanasiri, Liang Liu, Edward Yu, Sundar Jagannath

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4293087974

Cites:

Cited by:

Related to: 10